News

March 25, 2020March 25, 2020

GEN-1 Added to Chemo Improves Removal of Ovarian Tumors, Early Data Show

News

The immunotherapy candidate GEN-1 has shown encouraging results in patients newly diagnosed with advanced ovarian cancer, according to initial results of the OVATION 2 study. Adding GEN-1 to neoadjuvant ... Read more

March 23, 2020March 23, 2020

Cellular Recycling Genes Linked to Ovarian Tumor Formation in Mice, Study Shows

News

Disrupting genes essential for the cellular recycling process known as autophagy increases the frequency of mutations during cell division and promotes the formation of ovarian cancer tumors, a study ... Read more

March 20, 2020March 20, 2020

China Reviewing Zejula as First-line Therapy for Ovarian Cancer

News

The Chinese regulatory agency has agreed to review Zai Lab‘s application asking that Zejula (niraparib) be approved as first-line maintenance therapy for women with ovarian cancer who are responding ... Read more

March 18, 2020March 18, 2020

NCCN, AstraZeneca Projects Target Advanced Ovarian Cancer Patients

News

Four projects chosen by the National Comprehensive Cancer Network’s (NCCN) Oncology Research Program will explore ways to use technology to improve care for advanced ovarian cancer patients. Funded by ... Read more

March 16, 2020March 23, 2020

Cediranib-Lynparza Combo Fails to Delay Disease Progression in Relapsed Ovarian Cancer

News

A combination of the investigational therapy cediranib and Lynparza (olaparib) fails to delay disease progression in women with platinum-sensitive relapsed ovarian cancer compared with standard platinum-based chemotherapy, findings from a ... Read more

March 13, 2020March 23, 2020

CytoDyn Cleared to Start Phase 2 Basket Trial of Leronlimab for Multiple Solid Cancers

News

CytoDyn has been cleared by an institutional review board to start a Phase 2 trial testing its investigational therapy leronlimab (PRO 140) to treat about 22 different solid cancers, including ... Read more

March 11, 2020March 11, 2020

‘Cycle for Survival’ Fundraiser Surpasses $250 Million Milestone

News

Including donations from more than 1 million individuals across all 50 states, 13-year-old Cycle for Survival has raised more than $250 million to date to fight rare malignancies such ... Read more

March 9, 2020March 9, 2020

Viral Vector Reformulated for Ovarian Cancer CAR T-cell Therapy, Anixa Says

News

Anixa Biosciences and Moffitt Cancer Center have completed the development and validation of a new viral vector designed to improve the efficacy of their immunotherapy candidate for ovarian cancer, ... Read more

March 6, 2020March 23, 2020

Women With Low LDL Have Lower Ovarian Cancer Risk, Genetic Analysis Shows

News

Women with naturally lower levels of LDL cholesterol have less risk of ovarian cancer, regardless of mutations in BRCA genes, a genetic analysis study revealed. The findings suggest a ... Read more

March 5, 2020March 5, 2020

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

News

In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the ... Read more

Pin It on Pinterest